Why Do ‘True’ Orphan Medicines Have Such A Low Acceptance Rate When Assessed By The SMC?
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.975
https://www.valueinhealthjournal.com/article/S1098-3015(17)31309-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
929
First Page :
A570
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31309-8&doi=10.1016/j.jval.2017.08.975